|
|
Volumn 358, Issue 9281, 2001, Pages 578-
|
|
The Global Health Fund: Moral imperative or industry subsidy?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BRAZIL;
COMPETITION;
COST;
DEVELOPING COUNTRY;
DRUG INDUSTRY;
DRUG MANUFACTURE;
ECONOMIC DEVELOPMENT;
EUROPEAN UNION;
FINANCIAL MANAGEMENT;
HEALTH CARE;
HUMAN;
INVESTMENT;
ITALY;
LICENSING;
MALARIA;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
PROPHYLAXIS;
PURCHASING;
SHORT SURVEY;
TECHNOLOGY;
TUBERCULOSIS;
UNITED STATES;
|
|
EID: 0035908765
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(01)05711-7 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (2)
|
